INCY
INCY
RSI 74 >70 overbought — rule excludes BUY
Price
Price at analysis
$106.32
The case
● Bull — what supports it
STRONG_TREND_UP, above both MAs, Phase 3 frontMIND win (25% risk reduction in DLBCL), Q1 rev +20%, Genesis AI + Vega Therapeutics M&A.
● Bear — what refutes it
RSI 74 OVERBOUGHT — explicit skip rule; pullback risk after +12% 3m.
What would change our mind
Drake commits in advance to what would prove this call wrong — falsifiers, not hindsight.
- Cooling to ~RSI 50 / pullback to 50DMA that holds.
The verdict
Sector analyst (Drake panel)–neutral
conviction 0.55
- RSI 74 >70 overbought — rule excludes BUY
- Wait for mean-reversion
Risks: RSI 74 OVERBOUGHT — explicit skip rule; pullback risk after +12% 3m.
Forward-only: this call is graded against the future, on its resolution date — never backfilled. This run carries a single synthesized panel verdict; multi-specialist runs list each view above.